Patents

US 11970526 B2: IL4/IL13 receptor molecule for veterinary use

Granted
2024-04-30
Filed
2018-04-20 application 16605356
Type
Utility · 34 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided are various embodiments relating to interleukin 13 receptor subunit alpha-1/interleukin 4 receptor subunit alpha (IL13R/IL4R) contiguous polypeptides derived from companion animal species and that bind to IL13 and/or IL4. Such contiguous polypeptides can be used in methods to treat IL13 and/or IL4-induced conditions in companion animals, such as canines, felines, and equines.

Source: PVGPATDIS, file of 2026-04-10 (ipg240430.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Elanco US Inc. 52 patentsUS company or organizationGreenfield, INPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Hangjun ZhanFoster City, CA17PVGPATDIS, file of 2026-04-10
Lam NguyenUnion City, CA30PVGPATDIS, file of 2026-04-10
Fawn QianBurlingame, CA4PVGPATDIS, file of 2026-04-10
Shyr Jiann LiMillbrae, CA18PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/715PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K38/1793PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P17/00PVGPATDIS, file of 2026-04-10
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N33/6869PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-12-03Security interest Security interest
Assignment of security interest in patent rights, recorded on october 20, 2021, at reel/frame 057861/0905
GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT signed 2025-10-31JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT CHICAGO, IL73815/912PASDL, file of 2026-10-15
2023-10-02Merger
Merger and change of name
KINDRED BIOSCIENCES, INC. signed 2022-03-24
ELANCO US INC. signed 2022-03-24
ELANCO US INC. GREENFIELD, IN65091/55PASDL, file of 2026-10-15
2023-03-09Assignment
Assignment of assignor's interest
ZHAN, HANGJUN signed 2023-02-23
NGUYEN, LAM signed 2023-02-24
LI, SHYR JIANN signed 2023-02-25
QIAN, FAWN signed 2023-02-27
KINDRED BIOSCIENCES, INC. BURLINGAME, CA62933/831ECORSEXC, file of 2026-09-25
2021-10-20Security interest Security interest
Security interest
KINDRED BIOSCIENCES, INC. signed 2021-10-18GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT JERSEY CITY, NJ57861/905PASDL, file of 2026-10-15
2020-05-13Assignment
Assignment of assignor's interest
LI, SHYR JIANN signed 2017-07-11
NGUYEN, LAM signed 2017-07-11
ZHAN, HANGJUN signed 2017-07-11
QIAN, FAWN signed 2017-07-14
KINDRED BIOSCIENCES, INC. BURLINGAME, CA52648/143ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.